Merck - Gardasil: questions, questions

Research findings from a safety review published in JAMA on Tuesday indicated that Merck & Co.'s cervical cancer vaccine Gardasil was associated with higher rates of blood clots and fainting compared with other vaccines, but that there was no evidence severe adverse events were caused by the product. In a separate article in JAMA, researchers who studied Merck's marketing practices for the vaccine questioned the "methods and messages by which [Gardasil] was marketed." Full story